Transition Therapeutics transitiontherapeutics.com


Public lists: Pharma Startups (4733)

Transition Therapeutics is a biopharmaceutical development company aiming to advance novel therapeutics for CNS, metabolic diseases and androgen deficiency indications.

Transition Therapeutics is a biopharmaceutical development company aiming to advance novel therapeutics for CNS, metabolic diseases and androgen deficiency indications.

Company (Acquired)

Phone: 416-260-7770

Fax:

101 College St
Suite 220
Toronto, M5G 1L7
Ontario, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Transition Therapeutics $0M Jun 30, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Transition Therapeutics Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods of synthesis of scyllitol and related compounds Oct 13, 2011 Nov 18, 2014 Patent
Vasoactive intestinal polypeptide pharmaceuticals Apr 10, 2006 Sep 29, 2009 Patent
Vasoactive intestinal polypeptide pharmaceuticals Oct 07, 2005 Jul 28, 2009 Patent